Geron Corporation’s $198 Million Upsized Public Offering

Cooley advised Geron, while Latham & Watkins represented the underwriters in the offering.Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, has announced the pricing of…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now